AblationforCardiacArrhythmias near Newark, NJ

Biography: Dr. Evelyn Horn is the Director of the Perkin Heart Failure Center of Weill Cornell, specializing in Heart Failure, Pulmonary Hypertension, and Mechanical Circulatory Support.Patients referred to the Center include those with diagnoses of systolic heart failure, valvular heart disease, preserved EF heart failure; pulmonary vascular disease - idiopathic, associated and secondary.Evelyn M. Horn, M.D. is a graduate of Brown University, Mount Sinai Medical School where she also was a medical intern and resident. She completed cardiology at the Cedars Sinai/UCLA program and thereafter spent 2 years as a research fellow at Columbia College of Physicians and Surgeons understanding the beta adrenergic G protein complex in heart failure, the denervated heart and models of arrhythmias. She remained at Columbia University Medical Center in the Divisions of Circulatory Physiology and Cardiology Center for Advanced Cardiac Care where she was at various times, Director of the Circulatory Physiology fellowship program, Director of Clinical Services for Heart Failure, Associate Director of the combined Pediatric & Adult Pulmonary Hypertension Center and Director of the Pulmonary Vascular program of the Center for Advanced Cardiac Care. She also was the director of the High Risk Cardiac Obstetrical program. She received numerous awards as clinician educator, continues to participate in clinical research in the areas of cardiac and vascular remodeling in heart failure and pulmonary hypertension.The Heart Failure program provides management of advanced heart failure (both systolic and diastolic), congenital heart disease, perioperative management of conventional cardiac surgical patients (high risk patients and high risk valve surgery), and ventricular assist devices. The center also offers rare expertise in the management of pulmonary hypertension, including idiopathic pulmonary hypertension and pulmonary hypertension associated with diseases such as connective tissue disease, congenital heart disease as well as a huge number of patients who have it in association with left heart disease and others have it associated with lung disease, certain hematological diseases or liver disease. Pulmonary hypertension and right heart failure complicates the management of about 1/3 of the patients with heart failure. In many, right heart failure follows left heart failure but management of difficult "cases" may require a special expertise and understanding of the interdependence of the right and the left ventricles. If cases become complicated by secondary pulmonary hypertension or right heart failure, most of Dr. Horn's colleagues seek out the "right heart doctor," as she has sometimes been called or the combined left and right heart doc.The phenotype of heart failure has multiple etiologies, and not all heart failure behaves the same way. Because of the nuances and subtleties involved in advanced heart failure, she stresses the importance of the multidisciplinary, collaborative center. Moreover, Dr. Horn points to the center's expertise in identifying the appropriateness and the optimal timing of therapeutic interventions. "We have fantastic technologies and therapies available, but these may not be in every patient's best interest," she explains. "It is essential to understand when therapies will or will not work, and when one has to move beyond them, perhaps to mechanical assist devices or heart transplantation for heart failure and lung transplantation for pulmonary hypertension. If we wait too long, we may have missed the opportunity to treat a patient, but no one wants to resort to devices or transplantation before a patient absolutely needs it."Dr. Horn's clinical research interests have been in ventricular and vascular remodeling in pulmonary hypertension and heart failure. Specific areas have included RV imaging, pulmonary hypertension outcome studies, use of vasopressin in pulmonary hypertension, endothelial dysfunction in pulmonary hypertension, RV dysfunction in the perioperative patient population, complications of pulmonary hypertension therapy, and assessment of the non PAH pulmonary hypertension patient population. She has been actively involved in the care of patients with valvular heart disease and in particular comorbidities of ventricular dysfunction and/or pulmonary vascular disease. She has been actively involved in the care of patients needing ventricular assist device therapies as a bridging or destination device. Along with colleagues, she has authored papers in the field of newer therapies for pulmonary hypertension, epidemiological assessments of patients with pulmonary hypertension, genetics of pulmonary hypertension, and markers of vascular dysfunction. She has been involved in industry sponsored heart failure and pulmonary hypertension studies, industry sponsored investigator initiated studies and collaborative NIH studies in Heart Failure and Pulmonary Hypertension. She has also been the liaison to high risk cardiac OB programs for the care of the complicated cardiac OB patient.Research and invited lectures have been presented at major National and International meetings. She is a fellow of the International Pulmonary Vascular Research Institute, helping to establish ISLHT Pulmonary Hypertension Committee and has been the recipient of teaching awards at Columbia University. Dr. Horn has created a NY Pulmonary Hypertension consortium, a network of a dozen specialists from the tri-state area, to encourage ongoing collaborative studies in pulmonary hypertension.

Biography: Dr. Robert Leber, MD is an Interventional Cardiology Specialist who practices in New York, NY. He is 66 years old and has been practicing for 39 years. Dr. Robert Leber, MD is affiliated with Mount Sinai Morningside and Mount Sinai Hospital.

Care Philosophy: We are committed to delivering the best care and an exceptional patient experience We are devoted to providing services that are patient centered and compassionate and care for you as a person nbsp;

Biography: Dr. Ravi Karanam is a board-certified cardiothoracic surgeon at RWJBarnabas Health, and part of the Northern Department of Cardiothoracic Surgery, operating out of Newark Beth Israel Medical Center. Dr. Karanam's current role is as Director of the Cardiothoracic Surgery Fellowship Program at RWJBarnabas Health. Dr. Karanam has been a member of the Department of Cardiothoracic Surgery at Newark Beth Israel Medical Center since 1984 and the Department of Surgery at Saint Barnabas Medical Center since 1996. He received his medical degree from HKES Medical College in Gulbarga, Karnatake, India. His postdoctoral training included pediatrics, general surgery and cardiothoracic surgery at hospitals in both India and the U.S., including New York University Affiliate Hospital, Sound Shore Medical Center, New Rochelle, NY, and Newark Beth Israel Medical Center. Dr. Karanam's areas of special interest and expertise include aortic surgery; aortic allograft and autografts; minimally-invasive valve, bypass and arrhythmia surgery; transcatheter aortic valve replacement (TAVR); video-assisted thoracic surgery and trans-myocardial laser revascularization.

Biography: Dr. Frederic Sardari is a board-certified cardiothoracic surgeon at RWJBarnabas Health, and part of the Northern Department of Cardiothoracic Surgery, operating out of Newark Beth Israel Medical Center and Saint Barnabas Medical Center. Dr. Sardari's current role is as Chief of Cardiac Surgery at Saint Barnabas Medical Center and as Vice Chair of the Department of Cardiothoracic Surgery. Dr. Sardari received his medical degree from George Washington University School of Medicine, Washington, DC; and he completed his residency in cardiothoracic surgery at Loma Linda University Medical Center, Loma Linda, California. His areas of interest include Minimally-Invasive Valve Surgery, Trans-catheter Valve Replacement(TAVR); and the treatment of Atrial Fibrillation. Dr. Sardari has been involved in overseas medical missions for many years. He has lectured and performed surgery in Latin America, China, and the Middle East. Prior to his current role, Dr. Sardari was Associate Staff Surgeon at the Cleveland Clinic Foundation Department of Thoracic and Cardiovascular Surgery in Ohio.

Biography: Dr. Icilma Fergus, MD is a Cardiology Specialist who practices in New York, NY. She is 61 years old and has been practicing for 33 years. Dr. Icilma Fergus, MD is affiliated with Mount Sinai Hospital.

Biography: Dr. Pedro Moreno, MD is a Cardiology Specialist who practices in New York, NY. He is 65 years old and has been practicing for 41 years. Dr. Pedro Moreno, MD is affiliated with Mount Sinai Hospital and Mount Sinai Morningside.

Biography: Dr. Stern was born in Chicago Illinois but came to NYC a few months later and was raised in Greenwich village, New York. She graduated from the University of Chicago with an AB in 1986. She attended Medical school at NYU School of Medicine graduating in 1990. Internship, Residency and an additional year of Chief Residency were completed in 1994 at NYU Langone Medical Center/ Bellevue Hospital. She remained at NYU Langone Health to complete a fellowship in Cardiovascular Diseases in 1997 with a concentration in Echocardiography. She has been in clinical practice for the last twenty seven years at Murray Hill Medical Group PC/CareMount Medical Group/Optum. She has been taking care of patients in the primary care and hospital settings in a multi specialty group affiliated with NYU Langone Health. Since 1997 she had been on the faculty at NYU Langone Health as a Clinical Assistant Professor of Medicine. In addition to her clinical responsibilities she was the Medical Director of the ICAEL accredited non invasive testing suite at MHMG/CareMount/Optum. She is board certified in Cardiovascular Disease and Echocardiography.

Biography: Dr. Abdul Aleem Ameen, MD is a Cardiology Specialist in Jersey City, NJ. Dr. Ameen has more experience with Cardiac Electrical System Procedures than other specialists in their area. They are affiliated with medical facilities such as Jersey City Medical Center and Jersey City Medical Center. They are accepting new patients and have indicated that they accept telehealth appointments. Be sure to call ahead with Dr. Ameen to book an appointment.

Biography: Dr. Andrew J. Kaufman, an expert in advanced minimally invasive thoracic surgery and thoracic surgical oncology, is the Director of The Thoracic Surgery Airway Program and The Asian Thoracic Surgery Program at Mount Sinai, as well as the Associate Program Director for the Thoracic Surgery Residency Program. He attended New York University School of Medicine for medical school and general surgery training. He completed a two year research fellowship at Memorial Sloan-Kettering Cancer Center and was awarded a national TSFRE Research Fellowship Grant and the Chairman's Award for Excellence in Basic Science Research. Dr. Kaufman went on to complete his residency on the Thoracic Surgery track in cardiothoracic surgery, specializing in thoracic surgery, at Memorial Sloan-Kettering Cancer Center/New York Hospital Weill-Cornell Medical Center as the Memorial Fellow in General Thoracic Surgery where he received the Alumni Foundation Award for All-Around Clinical Excellence. He is certified by the American Board of Surgery and the American Board of Thoracic Surgery. Dr. Kaufman especially enjoys spending time with and getting to know the people he meets in the office and hospital. He is dedicated to the compassionate care of people and their families across all social, economic, and cultural backgrounds. Having lived and studied in China for two years, Dr. Kaufman is fluent in Mandarin and conversational in Cantonese. His background in Asian language and culture inspired the development of the Asian Thoracic Surgery Program at the Mount Sinai. The program focuses on providing the most advanced multidisciplinary care for the Asian community with the goal of integrating community outreach, patient education, and scientific research to provide comprehensive care in this important New York City population. Dr. Kaufman is clinically focused on advanced minimally invasive and lung sparing surgery for thoracic malignancies. These specialized cancer operations conserve lung tissue and preserve respiratory function with faster recovery times. Andrew has published and presented widely on his lung sparing techniques of Video Assisted Thoracoscopic Surgery (VATS) segmentectomy for early lung cancers as well as pleurectomy and decortication for malignant pleural mesothelioma. His research interests are focused on combining clinical, pathologic, and genetic data to better understand lung cancer in smokers and non-smokers. Dr. Kaufman works closely with the Interventional Pulmonary Division to locate and mark small early cancers with Navigational Bronchoscopy in order to facilitate VATS lung sparing segmentectomy. This collaboration is also essential to The Thoracic Surgery Airway Program, which focuses on the diagnosis and treatment of benign and malignant diseases of the trachea and airways, such as tracheobronchomalacia and tracheal stenosis, utilizing both surgical and interventional techniques. In his spare time, Dr. Kaufman enjoys spending time with his wife and two terrific daughters. He is an avid cook, guitarist, and tennis player.

Biography: Dr. Vivian Abascal, MD is a Cardiology Specialist who practices in New York, NY. She is 68 years old and has been practicing for 42 years. Dr. Vivian Abascal, MD is affiliated with Mount Sinai Hospital.

Biography: Dr. Laighold was born and raised in New York City and attended high school near Weill Cornell. Dr. Laighold graduated with honors from the University of Michigan, and then attended Weill Medical College of Cornell University. He completed his residency in internal medicine at Thomas Jefferson University Hospital in 2006 and his fellowship in cardiology at North Shore University Hospital/LIJ Medical Center in 2009.Dr. Laighold joined the faculty in 2024 from Northwell Health where he had worked since 2009. He previously was the Director of Clinical Cardiology at Southside Hospital and the Director of Noninvasive Structural Heart Program at North Shore University Hospital.

Biography: Dr. Daniel Lu graduated from Brown University with a Bachelor of Science in Biochemistry and Molecular Biology. He then completed his medical training as well as a Masters of Health Sciences at Yale School of Medicine, followed by internship and residency in Internal Medicine at the Hospital of the University of Pennsylvania. He then completed his subspecialty training in Cardiology at New York-Presbyterian Hospital - Weill Cornell Medical Center, and underwent further subspecialty training in Advanced Heart Failure and Transplant Cardiology at both NYP-Cornell and NYP-Columbia. Dr. Lu has co-authored numerous research papers in medicine and cardiology and maintains an active research interest investigating outcomes of treatment for heart failure and cardiogenic shock.

Care Philosophy: Patients and Families should know: Every surgery has risks, benefits and alternatives. Navigating the complex maze of medical options and treatments available requires experienced, mature and sound judgement. The patient is helped by offering consultation services with respect and consideration, and with the goal of maximizing the quality of life, reducing pain and suffering and expediting recovery.

Biography: Dr. Homan completed his fellowship in Cardiovascular Disease at NewYork-Presbyterian/Cornell, where he served as Chief Cardiology Fellow and undertook an additional year of laboratory training in cardiometabolic biology with Dr. James Lo. He completed his Internal Medicine residency at NewYork-Presbyterian/Columbia, before which he received his M.D. degree from the Icahn School of Medicine at Mount Sinai. Prior to medical school he earned a Ph.D. in Chemistry from Harvard University and received his B.S. degree in Chemistry from the University of Florida in Gainesville.Dr. Homan's research has focused on understanding the relationship between obesity and cardiovascular disease. During his cardiology fellowship at Weill Cornell, he studied the role of the innate immune system in obesity-related liver disease and heart failure, and he received the Glorney-Raisbeck Fellowship Award in Cardiovascular Disease. In his PhD research at Harvard University, he discovered a new class of endogenous lipid molecules that he named fatty acyl hydroxy fatty acids (FAHFAs), which were ultimately found to have anti-diabetic and anti-inflammatory properties.Dr. Homan is a fellow of the American College of Cardiology, a diplomate of the American Board of Clinical Lipidology and a member of the National Lipid Association, and member of the American Society of Echocardiography. He also speaks Spanish and French.

Biography: Dr. Feldman is an Assistant Professor of Medicine in the Division of Cardiology of the Department of Medicine at Weill Cornell Medical College and an Attending Physician at New York Presbyterian-Weill Cornell Medical Center.Dr. Feldman grew up in Framingham, Massachusetts and completed her undergraduate studies at the University of Pennsylvania. She earned her medical degree from Boston University School of Medicine, completed Internal Medicine residency at Beth Israel Deaconess Medical Center/Harvard Medical School, where she completed the Clinician Educator Track, fellowship in Cardiovascular Disease at Boston Medical Center/Boston University School of Medicine, and an additional fellowship in Cardio-Oncology at Memorial Sloan Kettering Cancer Center. After training, she founded and directed the Cardio-Oncology and Cardiac Amyloidosis programs at Rutgers New Jersey Medical School/University Hospital. In 2023, she joined the Cardiology Division at New York-Presbyterian/Weill Cornell Medical College as a full-time faculty member where she provides expertise in cardio-oncology, cardiac imaging, and medical education. She serves as the Director of the Cardio-Oncology program.Dr. Feldman is board certified in Internal Medicine, Cardiovascular Diseases, Echocardiography, Nuclear Cardiology, and Cardio-Oncology. She is a fellow of the American College of Cardiology, and a member of the American Heart Association, American Society of Nuclear Cardiology, and the International Society of Cardio-Oncology.